InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
6
Disclosed sells
0
T+90 hit rate
29%
T+90 mean return
+7.9%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Yecies Eric Harold, Directeur Juridique et Responsable de la Conformité. Insider active across 2 companies, notably LifeMD, Inc.. In total, 12 disclosures have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €265k. Activity tracked since 19 May 2021. The latest transaction was disclosed on 31 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
18,750 shares0Common StockSEC:0000912282-25-000358:0
50,000 shares0Common StockSEC:0000912282-25-000279:0
56,250 shares0Common StockSEC:0001362118-24-000012:0
150,000 sharesCommon StockSEC:0001362118-23-000044:0
11,500 shares@ US$2.6015.3% of flowCommon StockSEC:0001362118-23-000037:0
Ideal exit: 9 Mar 2024 (T+270)
5,000 shares@ US$3.140.0087% mcap9.4% of flowCommon StockSEC:0001362118-22-000022:0
Ideal exit: 9 Dec 2022 (T+270)
12,500 shares0Common StockSEC:0001362118-22-000006:0
12,500 shares0Common StockSEC:0001362118-22-000006
7,400 shares@ US$4.1215.0% of flowCommon Stock, par value $0.01SEC:0001362118-21-000045
Ideal exit: 20 Aug 2022 (T+270)
7,400 shares@ US$4.120.017% mcap17.7% of flowCommon Stock, par value $0.01SEC:0001362118-21-000045:0
Ideal exit: 20 Aug 2022 (T+270)
11,100 shares@ US$9.24100.0% of flowCommon StockSEC:0001362118-21-000011
Ideal exit: 13 Feb 2022 (T+270)
11,100 shares@ US$9.240.051% mcap55.1% of flowCommon StockSEC:0001362118-21-000011:0
Ideal exit: 13 Feb 2022 (T+270)
12 of 12 declarations
About Yecies Eric Harold
Eric Harold Yecies is the Chief Compliance Officer and General Counsel at LifeMD, Inc. He is responsible for managing the company's legal affairs and regulatory compliance.
